ArQule, Inc. (ARQL) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ArQule, Inc. (ARQL)

An SI Board Since April 2003

Posts	SubjectMarks	Bans	Symbol
545	40	0	ARQL

Emcee: tuck	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
120	<i>This may by the kind of result that provokes the need for the biomarker	keokalani'nui	-	8/9/2004
119	J Pathol. 2004 Jul;203(3):754-61. Related Articles, Links Expression of E2F	keokalani'nui	-	8/9/2004
118	Leg Mason: ArQule reported a 2Q04 results of a net loss of $134,000, or approxim	mopgcw	-	7/26/2004
117	the PR hit on points that I've been starved over. happy camper. will hit t	scaram(o)uche	-	7/24/2004
116	They are not a toot your own horn kind of company. Rick was wondering a couple o	tom pope	-	7/23/2004
115	The CC was not unpleasant. They don't like talking about what they've g	keokalani'nui	-	7/23/2004
114	According to Briefing, those are good numbers (but that's not been much hel	tom pope	-	7/23/2004
113	ArQule Announces Second Quarter Earnings, Appointment of Daniel D. Von Hoff to S	nigel bates	-	7/23/2004
112	[High Throughput Medicinal Chemistry for Efficient Drug Discovery] currentdrugd	tuck	-	7/10/2004
111	[Suppression of tumorigenesis by the p53 target PUMA] Hannon is on the forefron	tuck	-	6/10/2004
110	ARABE TIMOTHY C,Director,BUYS 3,000 ON 5/24/04 OF ARQL 2004-05-25 17:24 (New Yor	mopgcw	-	5/26/2004
109	just noticed..... short interest was up 29% last month. :-) :-)	scaram(o)uche	-	5/5/2004
108	Thanks! I'll have a go at it, but the next couple of days are crammed. May	scaram(o)uche	-	4/28/2004
107	[Puma is an essential mediator of p53-dependent and -independent apoptotic pathw	tuck	-	4/28/2004
106	Thanks, very much, for going through that exercise, gathering what you could. I	scaram(o)uche	-	4/27/2004
105	I don't think they're going to have one. ARQ-501 is still dosing in PI;	tuck	-	4/27/2004
104	Tuck, Any idea what the arql presence at asco will be this year?	rkrw	-	4/27/2004
103	GENE [Identification and characterization of inhibitors of bacterial enoyl-acyl	tuck	-	4/25/2004
102	'Pre-clinical work pointed to one indication in particular for p1b.' Th	keokalani'nui	-	4/21/2004
101	guidance for the year assumes no new deals.	scaram(o)uche	-	4/21/2004
100	Agree on all counts. I'm in at $6.30. A poster on Yahoo! said he trades AR	tuck	-	4/21/2004
99	I did. Well, not a flyer, but I increased my position. Really silly sell-down.	scaram(o)uche	-	4/21/2004
98	Folks seem to be noticing the higher burn rate. Perhaps forgetting that the Roc	tuck	-	4/21/2004
97	no adverse events among patients dosed to date. three patients at current dose.	scaram(o)uche	-	4/21/2004
96	>>Bioorg Med Chem Lett. 2004 May 3;14(9):2025-30. The design, preparati	tuck	-	4/19/2004

Go to reply# or date (mm/dd/yy):